Influenza in Children and Vaccination——Interpretation of AAP Committee on Infectious Diseases Recommendations for Prevention and Control of Influenza in Children(2018—2019)
First Clinical Medical College of Southern Medical University/Department of Pediatrics,Nanfang Hospital,Guangzhou 510515,China
SUN Shumei. Influenza in Children and Vaccination——Interpretation of AAP Committee on Infectious Diseases Recommendations for Prevention and Control of Influenza in Children(2018—2019)[J]. Chinese General Practice, 2019, 22(6): 621-626. DOI: 10.12114/j.issn.1007-9572.2019.00.010.
孙树梅. 《儿童流感的预防与控制建议(2018—2019年)》解读[J]. 中国全科医学, 2019, 22(6): 621-626. DOI: 10.12114/j.issn.1007-9572.2019.00.010.
[1]World Health Organization.Up to 650 000 people die of respiratory diseases linked to seasonal FLU each year[EB/OL].
[2017-12-14].http://www.who.int/mediacentre/news/releases/2017/season- al-flu/en/.
[2]秦强,申昆玲.儿童流感防治进展[J].中华流行病学杂志,2018,39(8):1060-1065.DOI:10.3760/cma.j.issn.0254-6450.2018.08.009.
QIN Q,SHEN K L.Development of influenza control programs in children[J].Chinese Journal of Epidemiology,2018,39(8):1060-1065.DOI:10.3760/cma.j.issn.0254-6450.2018.08.009.
[3]Committee on Infectious Diseases.Recommendations for prevention and control of influenza in children,2017—2018[J].Pediatrics,2017,140(4):l501-l503.
[4]中华医学会儿科学分会呼吸学组,《中华实用儿科临床杂志》编辑委员会.儿童流感诊断与治疗专家共识(2015年版)[J].中华实用儿科临床杂志,2015,20(17):1296-1303.DOI:10.3760/cma.j.issn.2095-428X.2015.17.005.
[5]国家卫生和计划生育委员会,国家中医药管理局.流行性感冒诊疗方案(2018年版)[J].中国病毒病杂志,2018,8(2):181-184.DOI:10.3969/j.issn.1671-96382018.02..020.
[6]UYEKI T M,BERNSTEIN H H,BRADLEY J S,et al.Clinical practice guidelines by the infectious diseases society of America:2018 update on diseases,treatment,chemoprophylaxis,and institutional outbreak management of seasonal influenza[J].Clin Infect Dis,2018.DOI:10.1093/cid/ciy866.
[7]Recommendations for Prevention and Control of Influenza in Children,2018—2019[EB/OL].[2018-11-02].http://pediatrics.aappublications.org/content/142/4/e20182367.
[8]Centers for Disease Control and Prevention.Prevention and control of seasonal influenza with vaccines:recommendations of the advisory committee on immunization practices——United States,2018-19 influenza season[J].MMWR Recomm Rep,2018,67(3):1-20.DOI:10.15585/mmwr.rr6703a1.
[9]GARTEN R,BLANTON L,ELAL A I A,et al.Update:influenza activity in the United States during the 2017-18 season and composition of the 2018-19 influenza vaccine[J].MMWR Morb Mortal Wkly Rep,2018,67(22):634-642.DOI:10.15585/mmwr.mm6722a4.
[10]FLANNERY B,REYNOLDS S B,BLANTON L,et al.Influenza vaccine effectiveness against pediatric deaths:2010—2014[J].Pediatrics,2017,139(5):e20164244.DOI:10.1542/peds.2016-4244.
[11]DUFFY J,WEINTRAUB E,HAMBIDGE S J,et al.Febrile seizure risk after vaccination in children 6 to 23 months[J].Pediatrics,2016,138(1):e20160320.DOI:10.1542/peds.2016-0320.
[12]LESSIN H R,EDWARDS K M,Committee on Practice and Ambulatory Medicine,et al.Immunizing parents and other close family contacts in the pediatric office setting[J].Pediatrics,2012,129(1):e247-253.DOI:10.1542/peds.2011-2937.
[13]ROBISON S G,OSBORN A W.The concordance of parent and child immunization[J].Pediatrics,2017,139(5):e20162883.DOI:10.1542/peds.2016-2883.
[14]ZAMAN K,ROY E,ARIFEEN S E,et al.Effectiveness of maternal influenza immunization in mothers and infants[J].N Engl J Med,2008,359(15):1555-1564.DOI:10.1056/NEJMoa0708630.
[15]MADHI S A,NUNES M C,CUTLAND C L,et al.Influenza vaccination of pregnant women and protection of their infants[J].N Engl J Med,2014,371(24):2340.DOI:10.1056/NEJMc1412050.
[16]VENKATESAN S,MYLES P R,LEONARDI-BEE J,et al.Impact of outpatient neuraminidase inhibitor treatment in patients infected with influenza A(H1N1)pdm09 at high risk of hospitalization:an individual participant data meta-analysis[J].Clin Infect Dis,2017,64(10):1328-1334.
[17]MUTHURI S G,VENKATESAN S,MYLES P R,et al.Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection:a meta-analysis of individual participant data[J].Lancet Respir Med,2014,2(5):395-404.DOI:10.1016/S2213-2600(14)70041-4.
[18]VESIKARI T,KIRSTEIN J,DEVOTA GO G,et al.Efficacy,immunogenicity,and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children:a multicentre,randomised controlled,observer——blinded,phase 3 trial[J].Lancet Respir Med,2018,6(5):345-356.
[19]TAPIA M D,SOW S O,TAMBOURA B,et al.Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali:a prospective,active-controlled,observer-blind,randomised phase 4 trial[J].Lancet Infect Dis,2016,16(9):1026-1035.DOI:10.1016/S1473-3099(16)30054-8.
[20]GROHSKOPF L A,SOKOLOW L Z,FRY A M,et al.Update:ACIP recommendations for the use of quadrivalent live attenuated influenza vaccine (LAIV4)-United States,2018-19 influenza season[J].MMWR Morb Mortal Wkly Rep,2018,67(22):643-645.DOI:10.15585/mmwr.mm6722a5.
[21]KELSO J M,GREENHAWT M J,LI J T,et al.Update on influenza vaccination of egg allergic patients[J].Ann Allergy Asthma Immunol,2013,111(4):301-302.DOI:10.1016/j.anai.2013.07.030.
[22]GREENHAWT M,TURNER P J,KELSO J M.Administration of influenza vaccines to egg allergic recipients:a practice parameter update 2017[J].Ann Allergy Asthma Immunol,2018,120(1):49-52.DOI:10.1016/j.anai.2017.10.020.
[23]Centersfor Disease Control and Prevention.Influenza antiviral medications:summary for clinicians[EB/OL].(2015-11-03)[2018-09-12].http://www.cdc.gov/flu/professionals/antivirals/ summary-clinicians.htm.
[24]孙正芸,刘海燕.国内外指南推荐的儿童流感治疗方案[J].中华实用儿科临床杂志,2017,32(18):1361-1363.DOI:10.3760/cma.j.issn.2095-428X.2017.18.001.
SUN Z Y,LIU H Y.Recommendations for treatment of influenza in children of guidelines at home and abroad[J].Chin J Appl Clin Peditra,2017,32(18):1361-1363.DOI:10.3760/cma.j.issn.2095-428X.2017.18.001.
[25]Centers for Disease Control and Prevention.Antiviral drugs:information for health care professionals[EB/OL].
[2018-09-12].www.cdc.gov/flu/professionals/antivirals/index.htm.
[26]Committee on Infectious Diseases. Recommendations for prevention and control of influenza in children,2017—2018[EB/OL].
[2018-10-10].http://pediatrics.aappublications.org/content/140/4/e20172550.
[27]FIORE A E,FRY A,SHAY D,et al.Antiviral agents for the treatment and chemoprophylaxis of influenza ——recommendations of the Advisory Committee on Immunization Practices (ACIP) [J].MMWR Recomm Rep,2011,60(1):1-24.
[28]BRADLEY J S,BLUMER J L,ROMERO J R,et al.Intravenous zanamivir in hospitalized patients with influenza[J].Pediatrics,2017,140(5):e20162727.DOI:10.1542/peds.2016-2727.
[29]CHAN-TACK K M,KIM C,MORUF A,et al.Clinical experience with intravenous zanamivir under an Emergency IND program in the United States (2011—2014)[J].Antivir Ther,2015,20(5):561-564.DOI:10.3851/IMP2944.
[30]WANG K,SHUN-SHIN M,GILL P,et al.Neuraminidase inhibitors for preventing and treating influenza in children (published trials only)[J].Cochrane Database Syst Rev,2012(4):CD002744.DOI:10.1002/14651858.CD002744.pub4.
[31]JEFFERSON T,JONES M A,DOSHI P,et al.Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children[J].Cochrane Database Syst Rev,2014(4):CD008965.DOI:10.1002/14651858.CD00895.pub4.